• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨髓基质细胞刺激需要内皮细胞 MT1-MMP 的血管生成程序。

Bone marrow stromal cells stimulate an angiogenic program that requires endothelial MT1-MMP.

机构信息

Department of Biomedical Engineering, University of California, Irvine, Irvine, CA, USA.

出版信息

J Cell Physiol. 2012 Nov;227(11):3546-55. doi: 10.1002/jcp.24056.

DOI:10.1002/jcp.24056
PMID:22262018
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3338896/
Abstract

Bone marrow-derived stromal/stem cells (BMSCs) have recently been characterized as mediators of tissue regeneration after injury. In addition to preventing fibrosis at the wound site, BMSCs elicit an angiogenic response within the fibrin matrix. The mechanistic interactions between BMSCs and invading endothelial cells (ECs) during this process are not fully understood. Using a three-dimensional, fibrin-based angiogenesis model, we sought to investigate the proteolytic mechanisms by which BMSCs promote vessel morphogenesis. We find that BMSC-mediated vessel formation depends on the proteolytic ability of membrane type 1-matrix metalloproteinase (MT1-MMP). Knockdown of the protease results in a small network of vessels with enlarged lumens. Contrastingly, vessel morphogenesis is unaffected by the knockdown of MMP-2 and MMP-9. Furthermore, we find that BMSC-mediated vessel morphogenesis in vivo follows mechanisms similar to what we observe in vitro. Subcutaneous, cellular fibrin implants in C.B-17/SCID mice form aberrant vasculature when MMPs are inhibited with a broad-spectrum chemical inhibitor, and a very minimal amount of vessels when MT1-MMP proteolytic activity is interrupted in ECs. Other studies have debated the necessity of MT1-MMP in the context of vessel invasion in fibrin, but this study clearly demonstrates its requirement in BMSC-mediated angiogenesis.

摘要

骨髓基质/干细胞 (BMSCs) 最近被描述为损伤后组织再生的介质。BMSCs 除了在创伤部位防止纤维化外,还在纤维蛋白基质中引发血管生成反应。在这个过程中,BMSCs 和浸润的内皮细胞 (ECs) 之间的机械相互作用还不完全清楚。我们使用基于纤维蛋白的三维血管生成模型,试图研究 BMSCs 促进血管生成的蛋白水解机制。我们发现 BMSC 介导的血管形成取决于膜型 1 基质金属蛋白酶 (MT1-MMP) 的蛋白水解能力。蛋白酶的敲低导致血管腔扩大的小血管网络。相比之下,MMP-2 和 MMP-9 的敲低对血管形态发生没有影响。此外,我们发现体内 BMSC 介导的血管形态发生遵循与我们在体外观察到的类似的机制。当用广谱化学抑制剂抑制 MMP 时,C.B-17/SCID 小鼠皮下细胞纤维蛋白植入物形成异常血管,而当 EC 中 MT1-MMP 蛋白水解活性被阻断时,只有非常少量的血管形成。其他研究曾就纤维蛋白中血管浸润是否需要 MT1-MMP 进行了争论,但这项研究清楚地表明其在 BMSC 介导的血管生成中的必要性。

相似文献

1
Bone marrow stromal cells stimulate an angiogenic program that requires endothelial MT1-MMP.骨髓基质细胞刺激需要内皮细胞 MT1-MMP 的血管生成程序。
J Cell Physiol. 2012 Nov;227(11):3546-55. doi: 10.1002/jcp.24056.
2
Crosstalk between neovessels and mural cells directs the site-specific expression of MT1-MMP to endothelial tip cells.新生血管与壁细胞之间的串扰将MT1-MMP的位点特异性表达导向内皮尖端细胞。
J Cell Sci. 2007 May 1;120(Pt 9):1607-14. doi: 10.1242/jcs.000679. Epub 2007 Apr 3.
3
Mesenchymal stem cells from adipose and bone marrow promote angiogenesis via distinct cytokine and protease expression mechanisms.脂肪和骨髓间充质干细胞通过不同的细胞因子和蛋白酶表达机制促进血管生成。
Angiogenesis. 2011 Mar;14(1):47-59. doi: 10.1007/s10456-010-9194-9. Epub 2010 Nov 21.
4
Bone marrow-derived mesenchymal stem cells enhance angiogenesis via their α6β1 integrin receptor.骨髓间充质干细胞通过其α6β1 整联蛋白受体增强血管生成。
Exp Cell Res. 2013 Nov 15;319(19):2964-76. doi: 10.1016/j.yexcr.2013.09.007. Epub 2013 Sep 19.
5
Up-Regulated Expression of Matrix Metalloproteinases in Endothelial Cells Mediates Platelet Microvesicle-Induced Angiogenesis.内皮细胞中基质金属蛋白酶的上调表达介导血小板微囊泡诱导的血管生成。
Cell Physiol Biochem. 2017;41(6):2319-2332. doi: 10.1159/000475651. Epub 2017 Apr 27.
6
Cdc42 and RhoA have opposing roles in regulating membrane type 1-matrix metalloproteinase localization and matrix metalloproteinase-2 activation.Cdc42和RhoA在调节1型膜基质金属蛋白酶的定位和基质金属蛋白酶-2的激活中发挥相反作用。
Am J Physiol Cell Physiol. 2008 Sep;295(3):C600-10. doi: 10.1152/ajpcell.00460.2007. Epub 2008 Jun 18.
7
MMP-2 and MMP-14 Silencing Inhibits VEGFR2 Cleavage and Induces the Differentiation of Porcine Adipose-Derived Mesenchymal Stem Cells to Endothelial Cells.MMP-2 和 MMP-14 的沉默抑制 VEGFR2 的裂解,并诱导猪脂肪间充质干细胞向血管内皮细胞分化。
Stem Cells Transl Med. 2017 May;6(5):1385-1398. doi: 10.1002/sctm.16-0329. Epub 2017 Feb 18.
8
Vascular regression and survival are differentially regulated by MT1-MMP and TIMPs in the aortic ring model of angiogenesis.在血管生成的主动脉环模型中,MT1 - MMP和基质金属蛋白酶组织抑制因子对血管消退和存活具有不同的调节作用。
Am J Physiol Cell Physiol. 2009 Aug;297(2):C471-80. doi: 10.1152/ajpcell.00019.2009. Epub 2009 Jun 3.
9
Endothelial tubulogenesis within fibrin gels specifically requires the activity of membrane-type-matrix metalloproteinases (MT-MMPs).纤维蛋白凝胶内的内皮细胞管状结构形成特别需要膜型基质金属蛋白酶(MT-MMPs)的活性。
J Cell Sci. 2002 Sep 1;115(Pt 17):3427-38. doi: 10.1242/jcs.115.17.3427.
10
Membrane-type matrix metalloproteinase-mediated angiogenesis in a fibrin-collagen matrix.膜型基质金属蛋白酶介导的纤维蛋白-胶原蛋白基质中的血管生成
Blood. 2003 Mar 1;101(5):1810-7. doi: 10.1182/blood-2002-05-1593. Epub 2002 Sep 19.

引用本文的文献

1
Fibrin-based Bioinks: New Tricks from an Old Dog.基于纤维蛋白的生物墨水:老方法的新应用
Int J Bioprint. 2020 Apr 29;6(3):269. doi: 10.18063/ijb.v6i3.269. eCollection 2020.
2
Deciphering the relative roles of matrix metalloproteinase- and plasmin-mediated matrix degradation during capillary morphogenesis using engineered hydrogels.利用工程化水凝胶解析在毛细血管形态发生过程中基质金属蛋白酶和纤溶酶介导的基质降解的相对作用。
J Biomed Mater Res B Appl Biomater. 2019 Nov;107(8):2507-2516. doi: 10.1002/jbm.b.34341. Epub 2019 Feb 19.
3
Cellular Based Strategies for Microvascular Engineering.基于细胞的微血管工程策略。
Stem Cell Rev Rep. 2019 Apr;15(2):218-240. doi: 10.1007/s12015-019-09877-4.
4
Microvascular Networks From Endothelial Cells and Mesenchymal Stromal Cells From Adipose Tissue and Bone Marrow: A Comparison.来自脂肪组织和骨髓的内皮细胞与间充质基质细胞的微血管网络:一项比较研究
Front Bioeng Biotechnol. 2018 Oct 25;6:156. doi: 10.3389/fbioe.2018.00156. eCollection 2018.
5
The therapeutic potential of bone marrow mesenchymal stem cells in premature ovarian failure.骨髓间充质干细胞治疗卵巢早衰的潜力。
Stem Cell Res Ther. 2018 Oct 4;9(1):263. doi: 10.1186/s13287-018-1008-9.
6
Effects of CoCl-simulated hypoxia on the expression levels of matrix metalloproteinases in renal adenocarcinoma cells and renal tubular epithelial cells.氯化钴模拟缺氧对肾癌细胞和肾小管上皮细胞中基质金属蛋白酶表达水平的影响。
Exp Ther Med. 2018 Aug;16(2):1454-1460. doi: 10.3892/etm.2018.6337. Epub 2018 Jun 21.
7
Evaluating the potential of endothelial cells derived from human induced pluripotent stem cells to form microvascular networks in 3D cultures.评估人诱导多能干细胞衍生的内皮细胞在 3D 培养中形成微血管网络的潜力。
Sci Rep. 2018 Feb 8;8(1):2671. doi: 10.1038/s41598-018-20966-1.
8
Effect of TGF-β1 on the Migration and Recruitment of Mesenchymal Stem Cells after Vascular Balloon Injury: Involvement of Matrix Metalloproteinase-14.转化生长因子-β1对血管球囊损伤后间充质干细胞迁移和募集的影响:基质金属蛋白酶-14的作用
Sci Rep. 2016 Feb 16;6:21176. doi: 10.1038/srep21176.
9
Adipose-derived stem cells increase angiogenesis through matrix metalloproteinase-dependent collagen remodeling.脂肪来源干细胞通过基质金属蛋白酶依赖性胶原蛋白重塑增加血管生成。
Integr Biol (Camb). 2016 Feb;8(2):205-15. doi: 10.1039/c5ib00277j. Epub 2016 Jan 13.
10
Vascularization mediated by mesenchymal stem cells from bone marrow and adipose tissue: a comparison.骨髓和脂肪组织来源的间充质干细胞介导的血管生成:一项比较。
Cell Regen. 2015 Oct 23;4:8. doi: 10.1186/s13619-015-0025-8. eCollection 2015.

本文引用的文献

1
Controlled activation of morphogenesis to generate a functional human microvasculature in a synthetic matrix.在合成基质中控制形态发生以生成功能性的人微血管。
Blood. 2011 Jul 21;118(3):804-15. doi: 10.1182/blood-2010-12-327338. Epub 2011 Apr 28.
2
Mesenchymal stem cells from adipose and bone marrow promote angiogenesis via distinct cytokine and protease expression mechanisms.脂肪和骨髓间充质干细胞通过不同的细胞因子和蛋白酶表达机制促进血管生成。
Angiogenesis. 2011 Mar;14(1):47-59. doi: 10.1007/s10456-010-9194-9. Epub 2010 Nov 21.
3
Deletion of cathepsin H perturbs angiogenic switching, vascularization and growth of tumors in a mouse model of pancreatic islet cell cancer.组织蛋白酶 H 的缺失会扰乱小鼠胰岛细胞癌模型中的血管生成转换、血管生成和肿瘤生长。
Biol Chem. 2010 Aug;391(8):937-45. doi: 10.1515/BC.2010.080.
4
Stromal regulation of vessel stability by MMP14 and TGFbeta.基质金属蛋白酶 14 和转化生长因子-β对血管稳定性的基质调控。
Dis Model Mech. 2010 May-Jun;3(5-6):317-32. doi: 10.1242/dmm.003863. Epub 2010 Mar 11.
5
Biomimetic hydrogels with pro-angiogenic properties.具有促血管生成特性的仿生水凝胶。
Biomaterials. 2010 May;31(14):3840-7. doi: 10.1016/j.biomaterials.2010.01.104. Epub 2010 Feb 24.
6
IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion.IL-4 诱导肿瘤相关巨噬细胞中的组织蛋白酶蛋白酶活性,从而促进癌症生长和侵袭。
Genes Dev. 2010 Feb 1;24(3):241-55. doi: 10.1101/gad.1874010. Epub 2010 Jan 15.
7
Bioartificial matrices for therapeutic vascularization.用于治疗性血管化的生物人工基质。
Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3323-8. doi: 10.1073/pnas.0905447107. Epub 2009 Dec 31.
8
Mesenchymal cells stimulate capillary morphogenesis via distinct proteolytic mechanisms.间质细胞通过不同的蛋白水解机制刺激毛细血管形态发生。
Exp Cell Res. 2010 Mar 10;316(5):813-25. doi: 10.1016/j.yexcr.2010.01.013. Epub 2010 Jan 11.
9
MT1-MMP controls human mesenchymal stem cell trafficking and differentiation.MT1-MMP 调控人骨髓间充质干细胞的迁移和分化。
Blood. 2010 Jan 14;115(2):221-9. doi: 10.1182/blood-2009-06-228494. Epub 2009 Nov 9.
10
Self-organization of engineered epithelial tubules by differential cellular motility.通过差异细胞运动实现工程化上皮小管的自组织
Proc Natl Acad Sci U S A. 2009 Sep 1;106(35):14890-5. doi: 10.1073/pnas.0901269106. Epub 2009 Aug 18.